Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Tumor NGS Detection Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4689188
    • |
  • 27 April, 2026
    • |
  • Global
    • |
  • 121 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Tumor NGS Detection market size was valued at US$ 2851 million in 2025 and is forecast to a readjusted size of US$ 7703 million by 2032 with a CAGR of 15.4% during review period.
The main purpose of NGS is to discover clinically treatable genetic variants and guide patient treatment.
This report is a detailed and comprehensive analysis for global Tumor NGS Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Tumor NGS Detection market size and forecasts, in consumption value ($ Million), 2021-2032
Global Tumor NGS Detection market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Tumor NGS Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Tumor NGS Detection market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tumor NGS Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tumor NGS Detection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent, Thermo Fisher Scientific, BGI Group, Roche Foundation Medicine, Sinopharm Group, Fosunpharma, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Tumor NGS Detection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Medical Equipment
Consumables
Market segment by Application
Companion Diagnostics
Early Cancer Screening
Drug Discovery
Other
Market segment by players, this report covers
Agilent
Thermo Fisher Scientific
BGI Group
Roche Foundation Medicine
Sinopharm Group
Fosunpharma
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
Perkin Elmer
Qiagen NV
Partek
Illumina Inc.
Pacific Biosciences of California Inc.
Life Technologies Corporation
GTH.O
Paradigm Diagnostics
Oxford Nanopore Technologies Ltd.
Eurofins Scientific S.E.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Tumor NGS Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Tumor NGS Detection, with revenue, gross margin, and global market share of Tumor NGS Detection from 2021 to 2026.
Chapter 3, the Tumor NGS Detection competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Tumor NGS Detection market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tumor NGS Detection.
Chapter 13, to describe Tumor NGS Detection research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Tumor NGS Detection by Type
    • 1.3.1 Overview: Global Tumor NGS Detection Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Tumor NGS Detection Consumption Value Market Share by Type in 2025
    • 1.3.3 Medical Equipment
    • 1.3.4 Consumables
  • 1.4 Global Tumor NGS Detection Market by Application
    • 1.4.1 Overview: Global Tumor NGS Detection Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Companion Diagnostics
    • 1.4.3 Early Cancer Screening
    • 1.4.4 Drug Discovery
    • 1.4.5 Other
  • 1.5 Global Tumor NGS Detection Market Size & Forecast
  • 1.6 Global Tumor NGS Detection Market Size and Forecast by Region
    • 1.6.1 Global Tumor NGS Detection Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Tumor NGS Detection Market Size by Region, (2021-2032)
    • 1.6.3 North America Tumor NGS Detection Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Tumor NGS Detection Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Tumor NGS Detection Market Size and Prospect (2021-2032)
    • 1.6.6 South America Tumor NGS Detection Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Tumor NGS Detection Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Agilent
    • 2.1.1 Agilent Details
    • 2.1.2 Agilent Major Business
    • 2.1.3 Agilent Tumor NGS Detection Product and Solutions
    • 2.1.4 Agilent Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Agilent Recent Developments and Future Plans
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific Tumor NGS Detection Product and Solutions
    • 2.2.4 Thermo Fisher Scientific Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.3 BGI Group
    • 2.3.1 BGI Group Details
    • 2.3.2 BGI Group Major Business
    • 2.3.3 BGI Group Tumor NGS Detection Product and Solutions
    • 2.3.4 BGI Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 BGI Group Recent Developments and Future Plans
  • 2.4 Roche Foundation Medicine
    • 2.4.1 Roche Foundation Medicine Details
    • 2.4.2 Roche Foundation Medicine Major Business
    • 2.4.3 Roche Foundation Medicine Tumor NGS Detection Product and Solutions
    • 2.4.4 Roche Foundation Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Roche Foundation Medicine Recent Developments and Future Plans
  • 2.5 Sinopharm Group
    • 2.5.1 Sinopharm Group Details
    • 2.5.2 Sinopharm Group Major Business
    • 2.5.3 Sinopharm Group Tumor NGS Detection Product and Solutions
    • 2.5.4 Sinopharm Group Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sinopharm Group Recent Developments and Future Plans
  • 2.6 Fosunpharma
    • 2.6.1 Fosunpharma Details
    • 2.6.2 Fosunpharma Major Business
    • 2.6.3 Fosunpharma Tumor NGS Detection Product and Solutions
    • 2.6.4 Fosunpharma Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Fosunpharma Recent Developments and Future Plans
  • 2.7 Novogene
    • 2.7.1 Novogene Details
    • 2.7.2 Novogene Major Business
    • 2.7.3 Novogene Tumor NGS Detection Product and Solutions
    • 2.7.4 Novogene Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Novogene Recent Developments and Future Plans
  • 2.8 Geneseeq
    • 2.8.1 Geneseeq Details
    • 2.8.2 Geneseeq Major Business
    • 2.8.3 Geneseeq Tumor NGS Detection Product and Solutions
    • 2.8.4 Geneseeq Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Geneseeq Recent Developments and Future Plans
  • 2.9 AmoyDx
    • 2.9.1 AmoyDx Details
    • 2.9.2 AmoyDx Major Business
    • 2.9.3 AmoyDx Tumor NGS Detection Product and Solutions
    • 2.9.4 AmoyDx Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 AmoyDx Recent Developments and Future Plans
  • 2.10 Burning Rock Medicine
    • 2.10.1 Burning Rock Medicine Details
    • 2.10.2 Burning Rock Medicine Major Business
    • 2.10.3 Burning Rock Medicine Tumor NGS Detection Product and Solutions
    • 2.10.4 Burning Rock Medicine Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Burning Rock Medicine Recent Developments and Future Plans
  • 2.11 Perkin Elmer
    • 2.11.1 Perkin Elmer Details
    • 2.11.2 Perkin Elmer Major Business
    • 2.11.3 Perkin Elmer Tumor NGS Detection Product and Solutions
    • 2.11.4 Perkin Elmer Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Perkin Elmer Recent Developments and Future Plans
  • 2.12 Qiagen NV
    • 2.12.1 Qiagen NV Details
    • 2.12.2 Qiagen NV Major Business
    • 2.12.3 Qiagen NV Tumor NGS Detection Product and Solutions
    • 2.12.4 Qiagen NV Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Qiagen NV Recent Developments and Future Plans
  • 2.13 Partek
    • 2.13.1 Partek Details
    • 2.13.2 Partek Major Business
    • 2.13.3 Partek Tumor NGS Detection Product and Solutions
    • 2.13.4 Partek Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Partek Recent Developments and Future Plans
  • 2.14 Illumina Inc.
    • 2.14.1 Illumina Inc. Details
    • 2.14.2 Illumina Inc. Major Business
    • 2.14.3 Illumina Inc. Tumor NGS Detection Product and Solutions
    • 2.14.4 Illumina Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Illumina Inc. Recent Developments and Future Plans
  • 2.15 Pacific Biosciences of California Inc.
    • 2.15.1 Pacific Biosciences of California Inc. Details
    • 2.15.2 Pacific Biosciences of California Inc. Major Business
    • 2.15.3 Pacific Biosciences of California Inc. Tumor NGS Detection Product and Solutions
    • 2.15.4 Pacific Biosciences of California Inc. Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Pacific Biosciences of California Inc. Recent Developments and Future Plans
  • 2.16 Life Technologies Corporation
    • 2.16.1 Life Technologies Corporation Details
    • 2.16.2 Life Technologies Corporation Major Business
    • 2.16.3 Life Technologies Corporation Tumor NGS Detection Product and Solutions
    • 2.16.4 Life Technologies Corporation Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Life Technologies Corporation Recent Developments and Future Plans
  • 2.17 GTH.O
    • 2.17.1 GTH.O Details
    • 2.17.2 GTH.O Major Business
    • 2.17.3 GTH.O Tumor NGS Detection Product and Solutions
    • 2.17.4 GTH.O Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 GTH.O Recent Developments and Future Plans
  • 2.18 Paradigm Diagnostics
    • 2.18.1 Paradigm Diagnostics Details
    • 2.18.2 Paradigm Diagnostics Major Business
    • 2.18.3 Paradigm Diagnostics Tumor NGS Detection Product and Solutions
    • 2.18.4 Paradigm Diagnostics Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Paradigm Diagnostics Recent Developments and Future Plans
  • 2.19 Oxford Nanopore Technologies Ltd.
    • 2.19.1 Oxford Nanopore Technologies Ltd. Details
    • 2.19.2 Oxford Nanopore Technologies Ltd. Major Business
    • 2.19.3 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product and Solutions
    • 2.19.4 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Oxford Nanopore Technologies Ltd. Recent Developments and Future Plans
  • 2.20 Eurofins Scientific S.E.
    • 2.20.1 Eurofins Scientific S.E. Details
    • 2.20.2 Eurofins Scientific S.E. Major Business
    • 2.20.3 Eurofins Scientific S.E. Tumor NGS Detection Product and Solutions
    • 2.20.4 Eurofins Scientific S.E. Tumor NGS Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Eurofins Scientific S.E. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Tumor NGS Detection Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Tumor NGS Detection by Company Revenue
    • 3.2.2 Top 3 Tumor NGS Detection Players Market Share in 2025
    • 3.2.3 Top 6 Tumor NGS Detection Players Market Share in 2025
  • 3.3 Tumor NGS Detection Market: Overall Company Footprint Analysis
    • 3.3.1 Tumor NGS Detection Market: Region Footprint
    • 3.3.2 Tumor NGS Detection Market: Company Product Type Footprint
    • 3.3.3 Tumor NGS Detection Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Tumor NGS Detection Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Tumor NGS Detection Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Tumor NGS Detection Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Tumor NGS Detection Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Tumor NGS Detection Consumption Value by Type (2021-2032)
  • 6.2 North America Tumor NGS Detection Market Size by Application (2021-2032)
  • 6.3 North America Tumor NGS Detection Market Size by Country
    • 6.3.1 North America Tumor NGS Detection Consumption Value by Country (2021-2032)
    • 6.3.2 United States Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Tumor NGS Detection Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Tumor NGS Detection Consumption Value by Type (2021-2032)
  • 7.2 Europe Tumor NGS Detection Consumption Value by Application (2021-2032)
  • 7.3 Europe Tumor NGS Detection Market Size by Country
    • 7.3.1 Europe Tumor NGS Detection Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 7.3.3 France Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Tumor NGS Detection Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Tumor NGS Detection Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Tumor NGS Detection Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Tumor NGS Detection Market Size by Region
    • 8.3.1 Asia-Pacific Tumor NGS Detection Consumption Value by Region (2021-2032)
    • 8.3.2 China Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 8.3.5 India Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Tumor NGS Detection Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Tumor NGS Detection Consumption Value by Type (2021-2032)
  • 9.2 South America Tumor NGS Detection Consumption Value by Application (2021-2032)
  • 9.3 South America Tumor NGS Detection Market Size by Country
    • 9.3.1 South America Tumor NGS Detection Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Tumor NGS Detection Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Tumor NGS Detection Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Tumor NGS Detection Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Tumor NGS Detection Market Size by Country
    • 10.3.1 Middle East & Africa Tumor NGS Detection Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Tumor NGS Detection Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Tumor NGS Detection Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Tumor NGS Detection Market Drivers
  • 11.2 Tumor NGS Detection Market Restraints
  • 11.3 Tumor NGS Detection Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Tumor NGS Detection Industry Chain
  • 12.2 Tumor NGS Detection Upstream Analysis
  • 12.3 Tumor NGS Detection Midstream Analysis
  • 12.4 Tumor NGS Detection Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Tumor NGS Detection. Industry analysis & Market Report on Tumor NGS Detection is a syndicated market report, published as Global Tumor NGS Detection Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Tumor NGS Detection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo